New cannabis SPAC raises $150 million in IPO for US acquisitions


Choice Consolidation Corp., a new cannabis industry special purpose acquisition company (SPAC), raised $150 million in an initial public offering on the Canadian NEO Exchange.

“We are thrilled to make our public market debut on the NEO Exchange as we begin our next phase of effecting our qualifying transaction with a focus on US cannabis acquisitions,” Choice Consolidation CEO Joe Caltabiano said in a news release issued Friday.

“Over the coming months, we look forward to effecting a transaction that will seek to create a best-in-class cannabis (multistate operator) operating across key limited license markets in the U.S.”

Choice Consolidation plans to target “existing strong single-state operators in markets with high barriers to entry, distressed assets that require minimal to moderate incremental capital to ‘turn on’ and paper licenses in targeted states that can be obtained on accretive terms,” according to the release.

Caltabiano, a co-founder of multistate marijuana operator Cresco Labs, resigned as president of the Chicago-based company last year.

Peter Kadens, who stepped down as CEO of Chicago-based Green Thumb Industries in 2018, is listed as Choice Consolidation’s lead director.

In the cannabis industry, SPACs such as Choice Consolidation have become an increasingly common way to quickly take companies public.

Shares of Choice Consolidation trade on the NEO Exchange as CDXX.UN.U.



Source link

Medical Disclaimer:

The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.

0 Shares:
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like